References
- StageTBBergmannTKKroetzDLClinical pharmacokinetics of paclitaxel monotherapy: an updated literature reviewClin Pharmacokinet201857171928612269
- LuHJiangZAdvances in antiangiogenic treatment of small-cell lung cancerOnco Targets Ther20171035335928138259
- KramerIHeuserAPaclitaxel pharmaceutical and pharmacological issuesEur Hosp Pharm199513741
- ZhaoMLeiCYangYAbraxane, the nanoparticle formulation of paclitaxel can induce drug resistance by up-regulation of p-gpPLoS One2015107e013142926182353
- ShishodiaSSethiGAggarwalBBCurcumin: getting back to the rootsAnn N Y Acad Sci2005105620621716387689
- MohandasKMDesaiDCEpidemiology of digestive tract cancers in India. V. Large and small bowelIndian J Gastroenterol199918311812110407566
- SinhaRAndersonDEMcDonaldSSGreenwaldPCancer risk and diet in IndiaJ Postgrad Med200349322222814597785
- KhorTOKeumYSLinWCombined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient miceCancer Res200666261362116423986
- MaheshwariRKSinghAKGaddipatiJSrimalRCMultiple biological activities of curcumin: a short reviewLife Sci200678182081208716413584
- ChoiBHKimCGLimYShinSYLeeYHCurcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathwayCancer Lett2008259111111818006147
- NeeratiPSudhakarYAKanwarJRCurcumin regulates colon cancer by inhibiting p-glycoprotein in in-situ cancerous colon perfusion rat modelJ Cancer Sci Ther2013531331924511364
- HofheinzRDGnad-VogtSUBeyerUHochhausALiposomal encapsulated anticancer drugsAnticancer Drugs200516769170716027517
- WesslerJDGripLTMendellJGiuglianoRPThe P-glycoprotein transport system and cardiovascular drugsJ Am Coll Cardiol201361252495250223563132
- ThadakapallyRAafreenAAukunuruJHabibuddinMJoqalaSPreparation and characterization of PEG albumin-curcumin nanoparticles intended to treat breast cancerIndian J Pharm Sci2016781657227168683
- ZetterBROn target with tumor blood vessel markersNat Biotechnol19971512124312449359101
- DanhierFLe BretonAPréatVRGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosisMol Pharm20129112961297322967287
- GarangerEBoturynDDumyPTumor targeting with RGD peptide ligands – design of new molecular conjugates for imaging and therapy of cancersAnticancer Agents Med Chem20077555255817896915
- ZitzmannSEhemannVSchwabMArginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivoCancer Res200262185139514312234975
- MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000651–227128410699287
- YaoQGutierrezDCHoangNHEfficient codelivery of paclitaxel and curcumin by novel bottlebrush copolymer-based micellesMol Pharm20171472378238928605595
- WeiYPuXZhaoLPreclinical studies for the combination of paclitaxel and curcumin in cancer therapy (Review)Oncol Rep20173763159316628440434
- TrottaMDebernardiFCaputoOPreparation of solid lipid nanoparticles by a solvent emulsification-diffusion techniqueInt J Pharm20032571–215316012711170
- KimSYLeeYMTaxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriersBiomaterials200122131697170411396872
- ShiBFangCYouMXStealth MePEG-PCL micelles: effects of polymer composition on micelle physicochemical characteristics, in vitro drug release, in vivo pharmacokinetics in rats and biodistribution in S180 tumor bearing miceColloid Polym Sci20052839954967
- TurnerEAStensonACYazdaniSKHPLC-MS/MS method for quantification of paclitaxel from keratin containing samplesJ Pharm Biomed Anal201713924725128324728
- MalhiSStescoNAlrushaidSLakowskiTMDaviesNMGuXSimultaneous quantification of reparixin and paclitaxel in plasma and urine using ultra performance liquid chromatography-tandem mass spectroscopy (UHPLC-MS/MS): application to a preclinical pharmacokinetic study in ratsJ Chromatogr B Analyt Technol Biomed Life Sci20171046165171
- ZhengZSunYLiuZZhangMLiCCaiHThe effect of curcumin and its nanoformulation on adjuvant-induced arthritis in ratsDrug Des Devel Ther2015949314942
- CaoYXuRXLiuZA high-throughput quantification method of curcuminoids and curcumin metabolites in human plasma via high-performance liquid chromatography/tandem mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci20149499507078